BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36902271)

  • 1. Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis.
    Shi Y; Liu W; Yang Y; Ci Y; Shi L
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.
    Wang F; Xu J; Xu SJ; Guo JJ; Wang F; Wang QW
    J Alzheimers Dis; 2022; 85(2):729-744. PubMed ID: 34776447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.
    Li J; Xu C; Zhang J; Jin C; Shi X; Zhang C; Jia S; Xu J; Gui X; Xing L; Lu L; Xu L
    Neurochem Res; 2021 Apr; 46(4):964-979. PubMed ID: 33586092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
    Fan LY; Yang J; Liu RY; Kong Y; Guo GY; Xu YM
    J Transl Med; 2023 Sep; 21(1):649. PubMed ID: 37735671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases.
    Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC
    Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic identification and experiment validation reveal 6 hub genes, promising diagnostic and therapeutic targets for Alzheimer's disease.
    Cao W; Ji Z; Zhu S; Wang M; Sun R
    BMC Med Genomics; 2024 Jan; 17(1):6. PubMed ID: 38167011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease.
    Kelly J; Moyeed R; Carroll C; Albani D; Li X
    Mol Brain; 2019 Feb; 12(1):16. PubMed ID: 30819229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated identification of key genes and pathways in Alzheimer's disease via comprehensive bioinformatical analyses.
    Yan T; Ding F; Zhao Y
    Hereditas; 2019; 156():25. PubMed ID: 31346329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Hub Genes in Alzheimer's Disease.
    Gui H; Gong Q; Jiang J; Liu M; Li H
    Comput Math Methods Med; 2021; 2021():6329041. PubMed ID: 34326892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of TAC1 Associated with Alzheimer's Disease Using a Robust Rank Aggregation Approach.
    Zhu M; Tang M; Du Y
    J Alzheimers Dis; 2023; 91(4):1339-1349. PubMed ID: 36617784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Kong P; Lei P; Zhang S; Li D; Zhao J; Zhang B
    Neurosci Lett; 2018 Jan; 662():51-58. PubMed ID: 28965931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3-Gene-Based Diagnostic Signature in Alzheimer's Disease.
    Wang H; Zhang Y; Zheng C; Yang S; Chen X; Wang H; Gao S
    Eur Neurol; 2022; 85(1):6-13. PubMed ID: 34521086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene network in pulmonary tuberculosis based on bioinformatic analysis.
    Li L; Lv J; He Y; Wang Z
    BMC Infect Dis; 2020 Aug; 20(1):612. PubMed ID: 32811479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.
    Tripathi R; Kumar P
    Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37635325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.